Chris Yan

Board Secretary, Head of Capital Market and IR @ D3 Bio

About

18 years diverse experiences in biotech, PE/VC, investment banking, Big 4, and consulting. Capital market strategy, investor relation, finance, business development, corporate strategy for healthcare companies from start-up to IPO stage

Country

China

City

Xuhui District

Industry

Biotechnology

Skill

Experience

Board Secretary, Head of Capital Market and IR

D3 Bio

2025-8 - Present · 1 yr 2 mos

Vice President - Capital markets and Finance

Ractigen Therapeutics

2024-12 - 2025-8 · 9 mos

Vice President - Head of Capital Markets and Finance

Ark Biosciences

2020-6 - 2024-11 · 4 yrs 6 mos

Shanghai

Executive Director

Sunland Capital

2017-8 - 2020-6 · 2 yrs 11 mos

Healthcare PE/VC investment

Vice President

China Renaissance 华兴资本

2015-3 - 2017-6 · 2 yrs 4 mos

Shanghai City, China

Manage origination and execution of private placement and M&A deals in healthcare sector

Senior Manager - Transaction Advisory Services

2010-5 - 2015-2 · 4 yrs 10 mos

Shanghai City, China

Review relevant business and financial information to identify critical investment risks; market research; build robust business and financial models to assess key value and risk drivers of the transaction targets Support management’s decision-making and deal negotiation, determine optimal ways to present business highlights to top management and/or investors Led valuation projects for financial reporting purposes

Consultant - Finance & Risk Consulting

Mercer

2006-12 - 2010-5 · 3 yrs 6 mos

Financial model review and development - project finance, M&A, business valuation in Asia Pacific and worldwide. Valuation of Executive Share Option Scheme - Black-Scholes, Binomial and Monte-Carlo methods Traditional actuarial valuation - DB pension scheme Employee benefit consulting - defined contribution pension plan consulting